Novel Ingredients in Infant Formula Market Set to Transform Infant Nutrition Through Bioactives and Functional Components by 2034

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Novel Ingredients in Infant Formula Market"-, By Product Type (Plant-Based Milk, Plant-Based Juices, RTD Tea & Coffee, Others), By Source (Nuts, Grains, Legumes, Fruits & Vegetables, Others), By Distribution Channel (Online, Offline), and Global Forecasts, 2024-2034 And Segment Revenue and Forecast To 2034."

Novel Ingredients in Infant Formula Market Size is predicted to grow at 8.7% CAGR during the forecast period for 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2977

In the context of infant nutrition, the term "novel ingredients" refers to bioactive compounds that extend beyond conventional macronutrients and micronutrients-such as proteins, fats, carbohydrates, vitamins, and minerals-to more accurately emulate the composition and functional properties of human breast milk. A prominent example is Milk Fat Globule Membrane (MFGM), a complex trilayer membrane that encapsulates fat globules in breast milk.

MFGM is rich in bioactive constituents, including phospholipids, cholesterol, and specialized proteins such as lactoferrin and osteopontin, which have been linked to enhanced cognitive development, neurological function, and immune support in infants. Recent technological advancements in extraction and stabilization processes have facilitated the incorporation of MFGM into commercially available infant formula products.

In parallel, the use of novel prebiotics-non-digestible dietary fibers that selectively stimulate the growth of beneficial gut microbiota-is gaining traction. Commonly used examples include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), both of which are recognized for their positive contributions to digestive health and overall well-being in infants.

There is a growing consumer demand for infant formulas that are fortified with functional ingredients aimed at supporting critical developmental domains such as immune function, digestion, and cognitive performance. This trend is particularly evident within the specialty formula category, which addresses the needs of infants requiring tailored nutritional solutions. The increasing integration of prebiotics, probiotics, and postbiotics highlights a broader industry focus on nurturing a healthy gut microbiome, now widely acknowledged as fundamental to immune system maturation.

Furthermore, advances in biotechnology have enabled the development of sophisticated components such as human milk oligosaccharides (HMOs) and MFGM, which closely replicate the key functional elements of breast milk. These innovations are significantly enhancing the nutritional value and efficacy of next-generation infant formulas, making them more viable alternatives for situations where breastfeeding is not possible.

List of Prominent Players in the Novel Ingredients in Infant Formula Market:
• DSM
• FrieslandCampina
• Novonesis (Chr. Hansen + Novozymes)
• DuPont (IFF Nutrition)
• BASF
• AAK
• Glycosyn
• Inbiose
• Kyowa Hakko
• Nestlé
• Danone (Nutricia)
• Abbott Nutrition
• Reckitt (Mead Johnson)
• Arla Foods
• Fonterra
• Helaina
• Biomilq
• 108LABS
• Turtletree Labs
• Else Nutrition
• ByHeart
• Sprout Organic
• Conagen
• Nature's One
• Bactolife
• Evonik
• Glycotope

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics
Drivers:
The increasing focus on infant health and nutrition is a major factor driving the adoption of advanced ingredients in the infant formula industry. Modern consumers are more informed and health-conscious, prompting strong demand for high-quality formula products enriched with components such as human milk oligosaccharides (HMOs), milk fat globule membrane (MFGM), and bioengineered proteins. These ingredients are recognized for their beneficial effects on immune function, digestive wellness, and cognitive development.

Additionally, the rising incidence of food allergies, gastrointestinal issues, and metabolic disorders among infants has led to growing demand for specialized, hypoallergenic formulations. To meet these evolving needs, manufacturers are investing heavily in research and development, aiming to introduce innovative, performance-oriented nutritional solutions.

Challenges:
Despite its promising outlook, the market faces several barriers to broader adoption of novel ingredients. A key obstacle is the complex and time-intensive regulatory approval process, which mandates strict validation of safety and efficacy prior to market entry. These requirements often lead to delays and increase compliance costs. Furthermore, the innovation and commercialization of new ingredients require significant investment in R&D and access to advanced production technologies. These capital and infrastructure demands can pose considerable challenges for smaller and mid-sized enterprises attempting to compete in this evolving space.

Regional Trends:
Asia-Pacific continues to dominate the infant formula market in terms of size and growth, fueled by relatively high birth rates, urban expansion, and growing household incomes. China plays a pivotal role in regional expansion, supported by favorable policy changes and a well-established retail ecosystem. However, shifting demographics-including declining birth rates and an aging population-are encouraging domestic producers to diversify into complementary categories such as adult nutrition.

Conversely, North America leads in the development and adoption of novel infant formula ingredients, underpinned by robust regulatory support and a strong focus on pediatric health. Consumers in this region increasingly prefer organic, non-GMO, and clean-label formulations, driven by heightened concerns around safety, quality, and supply chain transparency. These regional trends are shaping the global landscape for advanced ingredient integration in the infant nutrition sector.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2977

Recent Developments:
• In April 2025, DSM-Firmenich received approval from the FSSAI to use GLYCARE 2FL, a human milk oligosaccharide, in early-life nutrition products in India. This comes after the European Commission recently approved dsm-firmenich's HMO ingredient, LNFP-I. The company also just introduced Dry Vit A Palmitate, an early-life nutraceutical intended to treat vitamin A deficiency. Infants can now use the component 2'-O-Fucosyllactose (2'-FL), with a daily maximum suggested intake of 1.2 grams per liter of formula.
• In Oct 2024, dsm-firmenich, Launched Dry Vit A Palmitate for Early Life Nutrition, a ground-breaking clean-label solution created to improve the nutritional value of newborn formulae without the stability problems associated with conventional vitamin A components, was announced by leaders in health, nutrition, and beauty.
• In Sep 2023, Danone, the head of Danone's early life nutrition division and vice president announced a new newborn formula in China that contains milk droplets that closely resemble the structure of mothers' milk, according to Growth Asia.

Segmentation of Novel Ingredients in Infant Formula Market.
Global Novel Ingredients in Infant Formula Market - By Ingredient Type
• Human Milk Oligosaccharides (HMOs)
• Milk Fat Globule Membrane (MFGM)
• Synthetic/Bioengineered Proteins
• Next-Gen Probiotics
• Plant-Based Bioactives
• Glycomacropeptides (GMPs)
• Exosomes and MicroRNAs
Global Novel Ingredients in Infant Formula Market - By Application
• Standard Infant Formula
• Follow-On Formula
• Specialty Formula
• Growing-Up Milk
Global Novel Ingredients in Infant Formula Market - By Source
• Bioengineered
• Plant-Based
• Animal-Derived
Global Novel Ingredients in Infant Formula Market - By Region
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/novel-ingredients-in-infant-formula-market/2977

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.